(349) Molnupiravir vs Remdesivir for Treatment of Covid-19 in Lung Transplant Recipients

PURPOSE: Three SARS-CoV-2-directed anti-viral therapies are currently accessible in the United States: remdesivir (REM), molnupiravir (MOL), and nirmatrelvir+ritonavir. The latter has significant drug-drug interactions and is typically not used in lung transplant recipients (LTRs). We compared the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Razia, D., Sindu, D., Grief, K., Cherrier, L., Omar, A., Walia, R., Tokman, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068060/
http://dx.doi.org/10.1016/j.healun.2023.02.1653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068060/
http://dx.doi.org/10.1016/j.healun.2023.02.1653

Ejemplares similares